From genotype to phenotype: Behavior of the transgenic rat TGR(mRen2)27 as an example

Reviews in the Neurosciences

Volumn 11, Issue 1, 2000, Pages 37-45

  Voigt, Jörg Peter ^a   Rex, André ^a   Bader, Michael ^b   Fink, Heidrun ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Anxiety; Behavior; Microdialysis; Phenotype; TGR(mRen2)27; Transgenic rat

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SEROTONIN;

ANIMAL BEHAVIOR; ANXIETY; BRAIN PERFUSION; CONFERENCE PAPER; EXPERIMENTAL MODEL; GENE MUTATION; GENOTYPE; KNOCKOUT GENE; MAZE TEST; METHODOLOGY; MICRODIALYSIS; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; TRANSGENIC ANIMAL;

EID: 0033988188     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2000.11.1.37     Document Type: Conference Paper

References (44)

1. Anseloni VZ, Brandao ML. Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze. Behav Pharmacol 1997; 8: 533-540.
2. Belcheva I, Georgiev V, Chobanova M, Hadjiivanova C. Behavioral effects of angiotensin II microinjected into CA1 hippocampal area. Neuropeptides 1997; 31: 60-64.
3. Borawska M, Kupryszewski G, Witczuk B, Wisniewski K. Effects of angiotensin II and its fragments: angiotensin II(3-8)-hexapeptide and angiotensin II(4-8)-pentapeptide on retrieval in passive avoidance situation in rats chronically treated with ethanol. Pol J Pharmacol Pharm 1989; 41: 227-230.
4. Cadogan AK, Kendall DA, Fink H, Marsden CA. Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo. Behav Pharmacol 1994; 5: 299-305.
5. Costall B, Domeney AM, Gerrard PA, Horovitz ZP, Kelly ME, Naylor RJ, Tomkins DM. Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset. Pharmacol Biochem Behav 1990; 36: 13-20.
6. Crawley J. Unusual behavioral phenotypes of inbred mouse strains. Trends Neurosci 1996; 19: 181-182.
7. Crusio WE. Gene-targeting studies: new methods, old problems. Trends Neurosci 1996; 19: 186-187.
8. Cruz APM, Frei F, Graeff FG. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 1994; 49: 171-176.
9. Erdös EG, Johnson AR, Boyden NT. Hydrolysis of enkephalin by cultured human endothelian cells and by purified peptidyl dipeptidase. Biochem Pharmacol 1978; 27: 843-848.
10. File SE. Behavioural detection of anxiolytic action. In: Elliot JM, Heal DJ, Marsden CA, eds. Experimental Approaches to Anxiety and Depression. New York: John Wiley & Sons, 1992; 25-43.
11. File SE. The interplay between learning and anxiety in the elevated plus-maze. Behav Brain Res 1993; 58: 199-102.
12. Ganten D, Lindpaintner K, Ganten U, Peters J, Zimmermann, F, Bader M, Mullins M. Transgenic rats: New animal models in hypertension research. Hypertension 1991; 17: 843-855.
13. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 1996; 19: 177-181.
14. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Reply. Trends Neurosci 1996; 19: 472.
15. Georgiev V, Stancheva S, Kambourova T, Getova D. Effect of angiotensin II on the Vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain. Acta Physiol Pharmacol Bulg 1990; 16: 32-37.
16. Kadish I, Brown JW, Feng XH, Wyss JM, van Groen T. Chronic hypertension does not impair spatial learning in Sprague Dawley rats. Soc Neurosci Abstr 1997; 2122.
17. Kaiser FC, Palmer GC, Wallace AV, Carr RD, Fraser Rae L, Hallam C. Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze. NeuroReport 1992; 3: 922-924.
18. Kulikov A, Aguerre S, Berton O, Ramos A, Mormede P, Chaouloff F. Central serotonergic systems in the spontaneously hypertensive and Lewis rat strains that differ in the elevated plus-maze test of anxiety. J Pharmacol Exp Ther 1997; 281: 775-784.
19. Langheinrich M, Lee MA, Böhm M, Pinto YM, Ganten D, Paul M. The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects. Am J Hypertens 1996; 9: 506-512.
20. Lathe R. Mice, gene targeting and behavior: more than just genetic background. Trends Neurosci 1996; 19: 183-186.
21. Lee MA, Böhm M, Paul M, Bader M, Ganten U, Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol 1996; 270: E919-929.
22. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92: 180-185.
23. Marsden CA, Bickerdike M, Cadogan A, Wright I, Rex A, Fink H. Serotonergic mechanisms and animal models of anxiety. In: Hamon M, Ollat H, Thiébot M-H, eds. Anxiety: Neurobiology, Clinic and Therapeutic Perspectives. Colloque INSERM: John Libbey Eurotext, 1993; 232: 75-82.
24. Mendelsohn FAO, Allen AM, Chai SY, McKinley MJ, Oldfield BJ, Paxinos G. The brain angiotensin system: Insights from mapping its components. Trends Endocrinol Metab 1990; 1: 189-198.
25. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 344: 541-544.
26. Fellow S, Chopin Ph, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 1985; 14: 149-167.
27. Phillips MI Functions of angiotensin in the central nervous system. Ann Rev Physiol 1987; 49: 413-435.
28. Rex A, Marsden CA, Fink H. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology 1993; 110: 490-496.
29. Rodgers RJ, Cole JC. The elevated plus-maze: Pharmacology, methodology and ethology. In: Cooper SJ, Hendrie CA, eds. Ethology and Pharmacology. New York: John Wiley & Sons Ltd., 1994; 9-44.
30. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rat. Peptides 1994; 15: 919-926.
31. Shepherd J, Bill DJ, Dourish CT, Grewal SS, McLenachan A, Stanhope KJ. Effects of the selective angiotensin II receptor antagonists losartan and PD 123177 in animal models of anxiety and memory. Psychopharmacology 1996; 126: 206-218.
32. Silverman P. Animal Behavior in the Laboratory. London: Chapman and Hall, 1978.
33. Söderpalm B. The SHR exhibits less "anxiety" but increased sensitivity to the anticonflict effect of clonidine compared to normotensive controls. Pharmacol Toxicol 1989; 65: 381-386.
34. Tsutsumi K, Saavedra JM. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 1991; 261: R209-R216.
35. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Höhle S, Meffert S, Stoll M, Stroth U, Zhu Y-Z. Angiotensin receptors. J Hypertens 1996; 14 (Suppl 5): S95-S103.
36. Voigt JP, Rex A, Sohr R, Fink H. Hippocampal 5-HT and NE release in the transgenic rat TGR(mRen2)27 related to behavior on the elevated plus maze. Eur Neuropsychopharmacol 1999; 9: 279-285.
37. Wilson W, Voigt P, Bader M, Marsden CA, Fink H. Behaviour of the transgenic (mREN2)27 rat. Brain Res 1996; 729: 1-9.
38. Whitworth CE, Fleming S, Cumming AD, Morton JJ, Burns NJT, Williams, BC, Mullins, JJ. Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int 1994; 46: 1528-1532.
39. Wright IK, Upton N, Marsden CA. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology 1992; 109: 338-346.
40. Wright JW, Miller Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW. Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Res Bull 1993; 32: 497-502.
41. Wright JW, Harding JW. Brain angiotensin receptor subtypes AT-1, AT-2, and AT-4 and their functions. Regul Peptides 1995; 59: 269-295.
42. Wyss JM, Fisk G, van Groen T. Impaired learning and memory in mature hypertensive rats. Brain Res 1992; 592: 135-140.
43. Yokosawa H, Endo S, Ogura Y, Ishii S. A new feature of angiotensin-converting enzyme in the brain: hydrolysis of substance P. Biochem Biophys Res Comm 1983; 116: 735-742.
44. Zhao Y, Bader M., Kreutz R, Fernandez Alfonso M, Zimmermann F, Ganten U, Metzger R, Ganten D, Mullins JJ, Peters J. Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27. Am J Physiol 1993; 265: E699-707.